Home Depot reports Tuesday morning. Lowe’s reports Wednesday morning. Alibaba and Ross Stores report Thursday.

Their option chains are offering exactly what traders expect before a binary event: elevated implied volatility, rapid time decay, and the possibility of collecting several days of premium in one trade.

I am passing.

Last week’s journal showed why. I realized $2,452, but the covered-call legs I opened or rolled still moved approximately $3,102 against me. The premium was visible immediately. The obligation behind it became visible later.

This week I want the opposite setup: simple covered calls against shares I already own and cash-secured puts at prices where I would genuinely accept assignment. No spreads. No condors. No short option held through an earnings announcement.

The screen produced six candidates with approximately $471 of modeled gross premium. But the real number is not $471. It is the $51,923 of stock and cash obligation supporting those trades.

That ratio is the entire point of this article.

These are research candidates, not orders. Quotes are from the August 14 close and must be repriced after Monday’s open.

The six-trade screen

I split the list into three positions expiring Friday and three expiring September 18.

The list is deliberately uneven. NFLX has clean markets. VEEV and LYFT do not. One candidate offers $286 of modeled premium; another offers only $14.

I do not expect all six to qualify on Monday.

The goal is not to complete a checklist. The goal is to let price, liquidity, and assignment math eliminate the weak trades.

My highest-conviction structure is the NFLX ladder

I own 300 Netflix shares at an average cost of $79.92. Instead of selling three identical calls, I am considering one contract at each of three different exit levels:

• One August 21 $82 call for approximately $0.231

• One September 18 $85 call for approximately $0.946

• One September 18 $90 call for approximately $0.383

Netflix’s official August 14 close was $78.16.

The weekly $82 call prioritizes immediate decay. Its market was $0.23 by $0.24, with more than 7,000 contracts of both volume and open interest. The effective exit would be approximately $82.23.

The September $85 call balances income and upside. Its market was $0.94 by $0.98, and the effective exit would be approximately $85.95.

The September $90 call pays less, but preserves more upside. Its market was $0.38 by $0.40, and the effective exit would be approximately $90.38.

If all 300 shares were called away, the estimated combined gain versus my average cost, including the modeled option credits, would be approximately $1,880.

That sounds attractive. The risk is equally clear: a strong NFLX rally would cap the upside on every share.

Netflix reported in July. Its next earnings date is tentatively October 20, after both candidate expirations.

My minimum credits: $0.20 for the $82 call, $0.90 for the $85 call, and $0.35 for the $90 call.

VEEV offers the most premium and the least trustworthy quote

Veeva’s official August 14 close was $243.75. I own 100 shares at an average cost of $187.76.

The August 21 $250 call showed:

• Bid: $1.90

• Ask: $4.60

• Modeled sell fill: approximately $2.856

• Delta: approximately 0.35

• Effective exit: approximately $252.86

At the modeled fill, the call would generate about $285.60. If assigned, the estimated stock gain plus premium would be approximately $6,510 relative to my average cost.

Veeva reports on August 26, five days after the option expires. That lets me sell a short-dated call without carrying it through the earnings release.

But the $2.70 bid-ask spread is the warning. A midpoint is not money. The modeled $2.856 credit is not executable until a buyer actually fills it.

This is a patient limit-order candidate only. If the spread remains wider than $1 or the market will not pay at least $2.75, I will skip it.

HIMS is a small premium attached to a volatile obligation

Hims & Hers closed at $28.15. The August 21 $26 put was $0.13 by $0.17, with a modeled sell fill near $0.139.

That produces only $13.90 of modeled premium against $2,600 of assignment cash.

The effective purchase price would be approximately $25.86, or 8.1% below the official close.

HIMS reported earnings on August 10, so the option does not cross the next report. The result was weak: EPS was -$0.37 versus a -$0.05 estimate.

That is why a low delta is not enough. A -0.14 delta does not make the business risk disappear, and $14 is not meaningful compensation for owning 100 unwanted shares.

I would sell this put only if I genuinely want HIMS near $25.86. If the stock opens below $27.50, the original setup has changed and I will reassess.

My minimum credit: $0.13.

LYFT offers a better discount, but poor liquidity

Lyft’s official August 14 close was $17.48. The September 18 $15 put was quoted at $0.10 by $0.32, with a modeled sell fill near $0.155.

That creates:

• Approximately $15.50 of modeled premium

• $1,500 of assignment cash

• An effective purchase price near $14.85

• A 15.1% discount to the official close

• A short-put delta near -0.14

Lyft reported on August 6 and its next earnings date is tentatively November 4, after the option expires. The latest EPS result was $0.13 versus a $0.15 estimate.

The setup is simple. The market is not. The option traded only 34 contracts on Friday and displayed a $0.22 spread.

I will require at least $0.15 and use a limit order. If Lyft opens below $17, I will reassess rather than automatically selling the same strike.

The premium looks different beside the obligation

The four covered calls reserve:

• 300 NFLX shares worth $23,448 at the official close

• 100 VEEV shares worth $24,375 at the official close

The two cash-secured puts reserve:

• $2,600 for HIMS assignment

• $1,500 for LYFT assignment

That is $47,823 of stock plus $4,100 of cash, or $51,923 supporting the screen.

The modeled premium is $471, before fees and slippage. That is about 0.91% of the stock and cash obligation.

This does not make the trades bad. It makes the sizing visible.

The covered-call premium is payment for limiting upside on shares I already own. The put premium is payment for committing to buy shares after a decline. Neither is free income.

Why I am skipping the earnings premium

The week’s obvious high-volatility events are:

• Home Depot: August 18 before the open

• Lowe’s: August 19 before the open

• Alibaba: August 20 before the open

• Ross Stores: August 20 after the close

I am passing for three reasons.

First, an earnings move is discontinuous. A stock can gap through several strikes before the market opens, leaving no opportunity to adjust.

Second, elevated premium is not an edge by itself. It is the market’s price for accepting elevated uncertainty.

Third, last week already left me with meaningful stock, covered-call, and short-put exposure. I do not need a new binary event merely because the annualized premium looks attractive.

Sometimes the best premium trade is the one that preserves capital for the next week.

My ranking for Monday

Based on Friday’s markets, my order of preference is:

1. NFLX September 18 $85 covered call

2. NFLX August 21 $82 covered call

3. NFLX September 18 $90 covered call

4. HIMS August 21 $26 cash-secured put

5. VEEV August 21 $250 covered call

6. LYFT September 18 $15 cash-secured put

VEEV ranks fifth despite offering most of the premium because its displayed market is too wide. LYFT ranks last because the premium is small, volume is low, and the spread is large.

That ranking can change after one clean Monday quote.

The Monday rules

1. Wait 15-30 minutes after the open before trusting option markets.

2. Use limit orders only.

3. Reprice every contract; Friday’s quotes are not promises.

4. Do not lower minimum credits just to force fills.

5. Keep call quantities within shares already owned.

6. Sell puts only at prices where assignment is an acceptable stock purchase.

7. Trade fewer than six positions if only the clean markets qualify.

The highest premium is not always the best trade.

The better question is: What obligation am I accepting, and would I still want it if the premium were half as large?

Disclosure: I own shares of NFLX and VEEV. This article documents my personal research process and is not investment advice. Options involve risk, including assignment, capped upside, and loss of principal. Equity prices are official August 14, 2026 closes. Option quotes are Robinhood snapshots from the August 14 close and may change materially before an order can be entered. No candidate order was reviewed or placed.

• A product embedded in the financial system

• Extraordinary pricing power

• Very little capital intensity

• Expanding margins

• Aggressive share repurchases

For years, the problem was not the business. It was the valuation.

That has changed.

FICO closed August 14 at $1,085.78, down 45.7% from its 52-week high of $1,998.01. Yet the company just reported 26% quarterly revenue growth, raised fiscal-2026 revenue guidance to $2.53 billion, and produced $961 million of trailing free cash flow.

The selloff has brought the stock to approximately 29.5x guided GAAP earnings and 24.4x trailing free cash flow.

That is not a traditional value-stock multiple. It is a much more interesting price for one of the highest-quality businesses in financial data.

The question is whether the market is offering a rare entry point or correctly discounting a new era of mortgage-score competition, regulatory pressure, and debt-funded buybacks.

This is company research, not investment advice. Financial figures are from FICO’s filings and investor materials. The stock price is the official August 14, 2026 close.

FICO is really two businesses

FICO operates two segments: Scores and Software.

The Scores business owns the familiar consumer credit-risk models used across mortgages, auto loans, credit cards, and personal loans. FICO says its score is used by 90% of top U.S. lenders.

The Software business sells analytics, fraud tools, decisioning systems, and the cloud-based FICO Platform to enterprises.

They have very different economics.

In the latest quarter, Scores generated $458.9 million, or 68% of total revenue, at a 91% segment operating margin.

Software generated $215.3 million at a 26% segment margin.

Scores is the profit engine. Software is the second growth option.

That distinction matters because the investment case depends on both:

1. Scores must preserve its pricing power as mortgage competition increases.

2. FICO Platform must eventually turn rapid cloud growth into faster total Software growth.

The financial compounding is exceptional

FICO’s revenue increased from $1.32 billion in fiscal 2021 to $1.99 billion in fiscal 2025, a 10.9% compound annual growth rate.

Updated fiscal-2026 guidance calls for $2.53 billion, which would be approximately 27% growth in one year.

Free cash flow rose from $416 million in fiscal 2021 to $739 million in fiscal 2025. It has now reached $961 million on a trailing basis.

The quality of that growth is visible in the margins.

GAAP operating margin expanded from 38.4% in fiscal 2021 to 46.5% in fiscal 2025. Through the first nine months of fiscal 2026, it reached 53.2%.

FICO does not need factories, inventory, or a large physical distribution network to grow. The company spent only $28 million on capital expenditures during the first nine months of fiscal 2026 while producing $778 million of operating cash flow.

That is why revenue growth converts so efficiently into cash.

Scores growth is spectacular - and concentrated

Scores revenue grew 41% in the latest quarter. B2B Scores grew 49%, while mortgage-origination revenue grew 97%.

Management identified the main driver directly: a higher mortgage-origination score unit price.

This is the bull case in one sentence. FICO owns a tiny but essential input inside a very large financial transaction, and the price of that input can rise without materially changing the total cost of a mortgage.

The company is also changing distribution through its Mortgage Direct License Program. Its investor presentation lists three pricing options:

• Classic FICO at $4.95 per score plus a $33 funded-loan fee

• FICO Score 10T at $0.99 per score plus a $65 funded-loan fee

• A $10 per-score model for Classic FICO or FICO Score 10T

FICO says signed resellers represent approximately 60% of U.S. mortgage volume, and it is engaged with resellers representing about 90%.

The direct model can remove credit-bureau markups, improve pricing transparency, and let FICO capture more of the economics.

It is also a defensive move.

The mortgage monopoly is becoming a competitive moat

The strongest bear argument is no longer theoretical.

FHFA and HUD are implementing VantageScore 4.0 and FICO Score 10T for mortgage underwriting. Fannie Mae and Freddie Mac are immediately accepting Vantage-scored loans from approved lenders.

For decades, FICO benefited from being the required standard. The market is moving toward lender choice.

That does not mean lenders will abandon FICO overnight. Credit models sit inside underwriting systems, securitization processes, risk policies, and historical performance databases. Switching has operational and model-risk costs.

FICO also argues that its models have known performance through full credit cycles and remain the industry standard across multiple lending categories.

But the moat has changed.

It is shifting from mandated exclusivity toward installed distribution, historical trust, predictive performance, and workflow integration.

That can still be a powerful moat. It is not the same moat investors valued at the stock’s peak.

The Software headline hides a real platform transition

Software revenue grew only 2% in the latest quarter. That looks disappointing beside Scores.

Underneath the headline:

• Total Software ARR reached $816 million, up 10%

• Platform ARR reached $413 million, up 62%

• Platform revenue grew 66%

• Platform dollar-based net retention reached 148%

• Non-platform ARR declined 17%

The new platform is growing rapidly while legacy products shrink or migrate. Platform ARR exceeded non-platform ARR for the first time in Q3.

This is the classic problem with a successful transition: the new product can grow quickly while the old base masks the result.

The 148% platform retention rate is especially important. It means the same customer cohort expanded spending by nearly half over the year, before including new customers.

If platform growth remains strong after the legacy drag becomes smaller, Software could reaccelerate. If it does not, FICO remains increasingly dependent on Scores pricing.

Buybacks transformed the per-share story

FICO reduced shares outstanding from 27.568 million at fiscal year-end 2021 to 21.597 million in June 2026 - a 21.7% reduction.

That makes every dollar of earnings and free cash flow more valuable to each remaining share.

The pace accelerated dramatically:

• Fiscal-2025 repurchases: $1.415 billion

• First nine months of fiscal 2026: $3.046 billion

• Q3 alone: approximately $1.96 billion

FICO repurchased 1.705 million shares in Q3 at an average price of $1,149. The August 14 close was about 5.5% below that price.

The uncomfortable part is how the company funded the acceleration.

Total debt rose from $3.06 billion in September 2025 to $5.58 billion in June 2026. After subtracting cash, net debt was approximately $5.33 billion.

FICO can support meaningful debt because its cash generation is exceptional. But debt-funded repurchases are not automatically value creation. They work only when the stock is purchased below intrinsic value and the balance sheet retains enough flexibility for a downturn or competitive shock.

The buyback is both a strength and a risk:

• It accelerated per-share growth.

• It signals management conviction.

• It leaves less room for error if Scores pricing weakens.

The valuation finally looks reasonable - not obviously cheap

At the official August 14 close:

At the 52-week high, the same fiscal-2026 EPS guidance would imply more than 54x earnings. The current multiple is far less dependent on perfection.

But 24x free cash flow still assumes FICO will retain meaningful pricing power, defend mortgage adoption, and continue growing per-share cash flow.

Using current trailing free cash flow of approximately $44.50 per share:

These are not price targets. They show what the current valuation requires.

The base case does not need a return to the old 50x-plus earnings multiple. It needs continued double-digit free-cash-flow-per-share growth and a premium, but not extreme, terminal multiple.

The bear case is also instructive. If cash flow stops growing and the market values it at 20x, the implied value is near $890 - close to the recent 52-week low.

What I would watch from here

Five metrics will determine whether the thesis works:

1. Mortgage Scores growth: How much comes from sustainable adoption versus price increases?

2. VantageScore usage: Approval matters less than actual funded-loan volume and lender conversion.

3. Platform ARR and retention: Platform ARR growth near 60% and retention near 150% would support a Software reacceleration thesis.

4. Scores margin: A sustained decline from the current 91% would signal competition or distribution costs are changing the economics.

5. Net leverage: Cash flow should begin absorbing the debt added for the accelerated repurchase.

My conclusion

FICO is a better investment candidate at $1,086 than it was near $2,000, even though the business is reporting stronger revenue, cash flow, and margins.

The market has removed much of the valuation excess. It has not removed the business risk.

I would describe the stock as reasonably priced for an exceptional business, not conventionally cheap.

The most compelling part of the thesis is the combination of:

• 27% guided revenue growth

• $961 million of trailing free cash flow

• A 53% GAAP operating margin through nine months

• A share count that has fallen 22% since fiscal 2021

• A valuation reset to roughly 24x free cash flow

The reason not to treat it as a no-brainer is equally clear:

• Mortgage pricing drove much of the recent acceleration

• VantageScore is now an approved competitor

• Debt increased by more than $2.5 billion in nine months

• Management bought stock above the current price

The old FICO thesis was a monopoly plus an unlimited multiple.

The new thesis is more interesting: a deeply embedded financial standard, still demonstrating extraordinary economics, now priced as if competition and capital allocation actually matter.

That is finally a debate worth having.

Disclosure: This article is for educational purposes and is not investment advice. The author may buy or sell securities discussed without notice. Financial data comes from FICO’s fiscal-2025 Form 10-K, Q3 fiscal-2026 earnings release and investor presentation, SEC company facts, FHFA, and Robinhood’s official August 14, 2026 close.

That is the attractive headline. It is also incomplete.

The covered-call positions I opened or rolled during the same week were marked approximately $3,102 against me by Friday’s close. That does not mean the portfolio lost $3,102: the calls were covered by stocks that had appreciated. It means I had sold away some of that upside, and the option side of the trade was now showing the bill.

This was a profitable week. It was not a risk-free one, and it definitely was not a clean example of “passive income.”

Here is the complete journal.

This is a record of my own trades, not investment advice. Option marks can be noisy, especially when spreads are wide.

The scoreboard

Across Robinhood and Schwab, I realized:

The trade-level breakdown was:

The SOFI result was assignment-driven, not a discretionary stock sale. Five August 14 $18 covered calls were assigned, so 500 shares were called away at expiration. The $577.27 above is the realized stock result recorded by Robinhood for that event.

Every closed trade in this set was profitable. That sounds great, but a list of winners can still conceal weak decisions. Realized P&L only records what has ended. It says nothing about the risk that remains open or the upside I have capped.

The assignment that became a covered call

The most instructive trade was TTD.

I had sold four August 7 $15 puts for $97.34 after fees. The stock finished below the strike, so I was assigned 400 shares at $15, committing $6,000.

Assignment is often described as if it is automatically a failure. I do not think that is useful. The better question is whether I was genuinely willing to own the shares at the effective price.

After including the put premium, my effective basis was approximately $14.76 per share.

On Monday, I sold four September 11 $14.50 covered calls for another $197.34 after fees. If the shares are called away at $14.50, the put and call premiums are enough to make the entire sequence modestly profitable despite the lower exit strike.

That is the good version of the wheel: accept shares at a planned price, lower the basis, and sell a call at an exit that still produces an acceptable result.

The danger is pretending assignment does not use capital. At Friday’s close, the TTD shares were still showing an unrealized loss, while the covered calls had also moved against me. Combined, the new TTD stock-and-call position was approximately $315 underwater before including the original put premium.

The trade still had a path to a profit. It was not free money.

I closed HOOD, then immediately sold more HOOD risk

HOOD produced my best Schwab sequence of the week.

I bought 100 shares on August 4 at $90.25 and had sold an August 14 $100 covered call. On Monday I:

1. Bought the call back for a $109.68 profit.

2. Sold the shares at $94.08 for a $382.79 profit after fees.

That closed the stock-and-call sequence for $492.47.

Then I sold an August 21 $90 put for $226.34. One day later, I bought it back for $206.66, realizing only $19.68.

The small profit was less important than the decision to reduce risk. I replaced it with a September 18 $85 put for $329.33, moving the strike $5 lower and giving the trade more time.

This is where a weekly journal is more revealing than a screenshot of closed profits. I did not simply “win” on HOOD. I took profits in one structure, briefly reopened aggressive exposure, then adjusted to a lower strike.

Three rolls generated profit, but did not eliminate the obligation

In Robinhood, I rolled covered calls in FIG, HOOD, and DUOL.

The closing legs realized:

• FIG: +$778

• HOOD: +$157

• DUOL: +$48

The replacement orders also brought in net credits:

It is tempting to treat the $983 of realized profit and $380 of roll credits as a completed success.

But a roll is not an escape. It is a close and a new trade.

By Friday, the eight new FIG $24 calls were marked approximately $1,560 against me. FIG’s official August 14 close was $25.42, above the new strike. The roll bought two weeks and raised the strike by only $0.50.

That may still be acceptable if I am happy to sell 800 shares at $24. It is a poor trade if I am emotionally attached to keeping the shares.

The same question applies to every covered call: Would I actually sell the stock at the strike today?

If the answer is no, the premium is not compensation. It is bait.

The most surprising open loss was RDDT

I also sold two September 18 RDDT $190 calls for $330.

RDDT’s official August 14 close was $178.09, below the $190 strike, while the calls were marked near $8.33. The option legs were approximately $1,335 underwater.

That distinction matters. The option loss was not intrinsic value from RDDT already trading through the strike. It reflected the contract’s remaining time value and repricing. It is also not standalone portfolio P&L because the calls are covered by shares.

This is another version of the premium trap. A $330 credit feels fixed when it arrives, but the cost to close can expand even while the stock remains below the strike.

If RDDT later trades above $190, the calls will cap upside. At the August 14 close, however, the immediate issue was expensive optionality rather than an in-the-money call.

The new short puts carried more risk than the premiums suggested

In Schwab, I opened or retained several short puts:

• Two September 18 DRAM $43 puts

• One September 18 HOOD $85 put

• Two September 18 PINS $21 puts

• Three August 21 SOFI $18 puts

Together, those contracts represented $26,700 of assignment value.

The premiums were much smaller:

That is $789.64 collected against $26,700 of possible stock purchases. The percentages are simple premium-to-strike-notional figures, not annualized returns.

This is the number I need to focus on. The premium is the visible reward; the assignment value is the real position size.

At the account level, these puts were not all fully cash secured. Margin was supporting part of the exposure. That changes the risk materially. A collection of individually reasonable trades can become one leveraged trade when the same market decline pressures all of them at once.

I also bought 200 NFLX shares

One transaction had no premium attached: I bought 200 NFLX shares at a weighted average price of approximately $75.49, committing about $15,099.

Those shares can eventually support covered calls, but I do not want the existence of 200-share lots to force a trade. The call still needs an acceptable strike, enough premium, and a price where I am willing to exit the stock.

The inventory is not an instruction to sell calls immediately.

What actually worked

Three things worked well:

First, closing profitable short options early. CELH, MNDY, HIMS, DRAM, and the short-lived HOOD put all returned capital without waiting for expiration.

Second, accepting assignment with a plan. TTD was not pleasant, but the put premium, adjusted basis, and covered-call exit were all measurable.

Third, moving risk out in time and down in strike. The HOOD put adjustment from $90 in August to $85 in September improved the entry level rather than defending the original strike out of pride.

What did not work

The weak point was covered-call risk management and interpreting option-leg P&L without enough underlying-price context.

The Robinhood calls opened or rolled during the week were marked approximately $3,102 against me at Friday’s close. About $2,895 of that came from FIG and RDDT alone.

FIG had already crossed its strike. RDDT had not. Grouping both losses under the same “capped upside” explanation was inaccurate even though the combined option-leg mark was correct.

The second weakness was aggregate put exposure. Looking at each premium separately made the trades appear small. Looking at the $26,700 assignment value revealed the real commitment.

The lesson I am carrying into next week

My realized result was +$2,452.13. I am happy with it.

But the number I want to remember is not the profit. It is the $3,102 of pressure on the covered-call legs and the $26,700 of short-put assignment value.

Those figures explain what the closed-trade total cannot:

• Covered calls exchange upside for immediate cash.

• Rolling realizes one result while creating another obligation.

• Short-put premium is small relative to assignment capital.

• Assignment is manageable only when it was planned before entry.

Premium selling works best for me when it supports a stock decision I already want to make: buy at this price, or sell at that price.

When the premium becomes the reason for the trade, the strategy starts managing me.

Subscribe now

On Monday, Nike reported EPS of $0.35 against expectations of $0.28 — a beat that sent the stock moving on $11.3 billion in quarterly revenue. Tuesday delivered McCormick & Company at $0.66 vs. $0.60 estimate, followed by FactSet Research Systems at $4.46 vs. consensus, with revenue growth accelerating to a projected 9.7% from 8.2% prior. Wednesday’s Acuity Brands topped EPS estimates but missed on revenue.

The beat headlines will dominate the financial cables. But the real story is in the split — and what it reveals about which businesses are actually compounding and which are just riding a wave that’s already slowing down.

What Actually Happened

Let’s clear the scoreboard. This was a week of quality proving it’s quality, and cyclicals showing their teeth.

Nike came in at $0.35 EPS versus $0.28 expected, revenue of roughly $11.3 billion. Consensus was bracing for more pain from the turnaround under CEO Elliott Hill, and the company delivered a credible beat. The story isn’t one-quarter data — it’s the trajectory. Nike has been working through inventory normalization, brand refresh, and direct-to-consumer recalibration. A $0.07 beat is meaningful when the bar was set at distress levels.

McCormick at $0.66 vs. $0.60 estimate, with revenue exceeding expectations. This is the quietest compounder in the S&P 500. Spices. Seasonings. Flavor solutions. The kind of business that nobody gets excited about until you realize the stock has compounded at mid-teens returns for two decades. McCormick didn’t just beat — it continued a track record that makes it the prototype for the kind of businesses Qarp Fund exists to identify.

FactSet at $4.46 EPS, a beat against a consensus that had already been revised upward (from $4.37 estimate, with the EPS view itself moving higher from $1.67 to $1.84 in forward estimates). Revenue growth accelerating from 8.2% to a projected 9.7%. This is the data infrastructure play that benefits from exactly what’s happening across the market: more data, more users, more AI integration. Wall Street is spending on its tools at an accelerating clip.

Acuity Brands beat EPS estimates but missed on revenue — the “Earnings Top Estimates, Sales Miss” headline that tells you this is a margin story, not a growth story. Cost controls and operational efficiency propped up the bottom line while top-line demand softened. “Lackluster Lighting” isn’t the headline any analyst wanted to write, but it’s accurate for an industrial play exposed to commercial real estate and construction cycles.

The Pattern Nobody Is Talking About

Here’s the split that actually matters.

On one side of the line: businesses with durable, pricing-power moats that compound through cycles. McCormick doesn’t care if consumers are trading up or trading down — they still buy flavor. FactSet doesn’t care if the Fed cuts or holds — the data has become more essential, not less, as AI makes raw financial information more abundant but the interpretation of that information more valuable.

On the other side: businesses fighting for their narrative. Nike is in a multi-year turnaround that might be working, but one beat doesn’t a compounder make. Acuity is managing through a cycle that’s not broken yet but isn’t growing either — the classic “good company, wrong quarter” problem.

The quality premium isn’t about today’s beat. It’s about what tomorrow looks like. McCormick’s next quarter looks like this one. FactSet’s next quarter looks like this one, but with 20 basis points more margin. Nike’s next quarter could look like this one or it could look like the three that came before — that’s the difference between certainty and hope.

What Management Said

On FactSet’s accelerating momentum:

“Revenue and EPS came in ahead of consensus, indicating operational momentum amidst a competitive landscape driven by AI and data expansion.”

On McCormick’s steady hand:

McCormick reported revenue exceeding estimate — the understatement of earnings season. In a market where $60 million in upside moves indices by two points, doing exactly what you said you’d do plus 10% is the ultimate flex.

On Nike’s turnaround:

Nike’s beat came with $11.28 billion in revenue — enough to be the world’s largest athletic apparel company by a wide margin, but now fighting a war on three fronts: against emerging DTC brands, against its own past direct-to-consumer overreach, and against the consumer who’s been told the brand has lost its edge.

The Trade

Here’s how to position around this split.

Own the compounders, rent the turnarounds. FactSet and McCormick belong in portfolios for five-year holds, not five-day trades. The margin expansion story at FDS (9.7% revenue growth with rising margins) is one of the highest-quality growth profiles in the S&P right now. McCormick, trading at a fair multiple for a business with this kind of predictability, is the definition of a buy-and-forget compounder.

Watch Nike for the second consecutive beat. If next quarter NKE beats again, the market starts believing in the turnaround, and you get a re-rating from “distressed brand” to “resurgent giant.” That’s a 20-30% upside move from current levels. But you’re buying a story, not a track record — size accordingly.

Skip Acuity for now. Beat EPS on flat or declining revenue is a recipe, not a moat. When cost cuts have nowhere left to go, the stock has nowhere to run. Revisit when top-line growth re-accelerates.

The broader signal: RH’s revenue guidance coming in 10.2% below estimates and Dave & Buster’s double miss the same week are not isolated events. They are data points in a consumer that is bifurcating — value shoppers are fine (McCormick holds, Cal-Maine crushes), but the premium consumer is pulling back. That’s a rotation story you can trade.

The Risk

The bull case on quality compounders at these levels: they’re not cheap. FactSet trades at a multiple that assumes continued AI-driven acceleration. McCormick at its current valuation assumes the spice business grows like clockwork forever. Both assumptions are reasonable until they aren’t. If interest rates tick up materially, the premium you pay for quality compresses the fastest.

Nike is the biggest risk here — if the turnaround stalls, you’re paying a premium for a brand that’s been losing market share to On, Hoka, and New Balance for three consecutive years. One beat doesn’t change a three-year thesis.

Acuity’s risk is straightforward: commercial real estate stays in the doldrums, construction spending softens, and there are no more cost cuts to find.

Numbers That Matter

NKE: EPS $0.35 vs $0.28 estimate, Revenue ~$11.3B — Beat

MKC: EPS $0.66 vs $0.60 estimate, Revenue > estimate — Beat

FDS: EPS $4.46 vs $4.37 estimate, Revenue +9.7% — Beat, accelerating

AYI: Beat EPS, Missed Revenue — Mixed

The takeaway is simple: in a quarter where the consumer is sending mixed signals, the compounders compounding are the ones with businesses that exist above the fray, not dependent on it.

Until next time,

Qarp Fund

We went through the Q4 2025 13F filings from eight major superinvestors to find out. The answer isn’t what most pundits are saying.

The short version: There is no unified “tech rota…

Read more

Read more

March 2026 • Q4 2025 13-F Analysis • 82 portfolios • ~$2 trillion in AUM

There’s a game the smartest money managers in the world play every quarter. They’re required by law to disclose their U.S. equity positions 45 days after each quarter ends. By the time retail investors read about it, the institutions are often already three moves ahead.

But here’s what most people miss: the signal isn’t in any single manager’s portfolio — it’s in the overlap.

When 16 different superinvestors all add to the same stock in the same quarter, that’s not coincidence. When 6 of the world’s best fund managers all open brand new positions in the same company simultaneously, that’s a coordinated moment of conviction worth paying attention to.

I scraped and analyzed all 82 superinvestor portfolios tracked by Dataroma — managers like Warren Buffett, Bill Ackman, David Tepper, Seth Klarman, Chase Coleman, and 77 others — and identified every buy and add from Q4 2025. Here’s what they’re telling us.

The Methodology (Quick Version)

• Source: Dataroma.com — 82 portfolios tracked, Q4 2025 13-F filings

• Scope: Every “Buy” (new position) and “Add” (position increase) event

• Total: 844 stocks with buy or add activity identified

• Distinction that matters: A “New Buy” means the manager opened a fresh position they didn’t hold before. An “Add” means they already owned it and bought more. Both are bullish, but new buys signal higher conviction.

• Current prices as of early March 2026

Chart 1: The Full Conviction Ranking

Green = New position opened. Blue = Existing position increased. Number inside green = count of new buys.

The Four Pillars of the Consensus Trade

1. Microsoft (MSFT) — 16 Investors Added. Zero Opened Fresh.

Microsoft is the most-added stock in the dataset by a wide margin. 16 separate superinvestors added to their MSFT positions in Q4 2025. That’s not a coincidence — that’s a coordinated recognition that the stock had gotten cheap enough to act on.

Here’s the twist: not a single one of those 16 opened a new position. Every one of them already owned it. What they did was buy more.

The numbers tell you why. Microsoft hit a 52-week high of $552 in mid-2024. By Q4 2025, it had pulled back to the mid-$400s — a roughly 25% drawdown in one of the most enduring compounding machines in the market. Azure cloud growth continues to accelerate, Copilot AI monetization is beginning to show up in enterprise contracts, and the company generates roughly $80 billion in free cash flow annually.

Among those adding: Chris Hohn’s TCI Fund, David Tepper, Stephen Mandel’s Lone Pine, Thomas Gayner, William Von Mueffling’s Cantillon Capital, Duan Yongping (the legendary Chinese value investor), and Francois Rochon — a geographically diverse group with wildly different investing styles, all arriving at the same conclusion.

Current price: $408.96 | 52-week range: $342 – $552 | Where it sits in range: Bottom third | Since Q4 filing: -15.4%

The stock has actually continued declining since the Q4 filing date. 16 managers thought it was cheap at ~$475. At $409, it’s even cheaper. The market is offering you a better price than they got.

2. Amazon (AMZN) — The Biggest Fresh Conviction Signal

If MSFT is the consensus add, Amazon is the consensus new buy — and that’s the more powerful signal.

6 superinvestors opened brand new Amazon positions in Q4 2025: David Rolfe (Wedgewood Partners), Dennis Hong (ShawSpring), Jensen Investment Management, Seth Klarman (Baupost Group), Thomas Russo, and Viking Global Investors. Five more added to existing positions.

That’s 11 total buy events, with more than half representing fresh capital deployment from managers who hadn’t previously held it (or hadn’t held it recently).

Why now? A few things converged in Q4 2025: AWS re-accelerated to 19% growth and is now running at an annualized $115B+ revenue rate; Amazon’s advertising business hit $60B+ for the year; and margins expanded dramatically as the company shifted from “build at all costs” back to “optimize and harvest.” The stock had also pulled back meaningfully from its 2024 highs.

Seth Klarman opening a new position is particularly notable. Baupost is known for deep value and special situations — not mega-cap tech. When Klarman buys Amazon, he’s saying the margin of safety has become compelling.

Current price: $213.21 | 52-week range: $161 – $259 | Where it sits in range: Middle | Since Q4 filing: -7.6%

3. Meta Platforms (META) — The AI Revenue Machine

10 managers bought or added Meta in Q4 2025, making it the third-most-acted-upon stock. Nine added to existing positions; Bill Ackman opened a new one.

Meta is increasingly the simplest AI investment thesis on the market: the company spent $40B+ on AI capex and is seeing direct revenue returns through ad targeting improvements. Instagram Reels is monetizing at YouTube-level rates. WhatsApp Business is barely scratched. And at roughly 22x forward earnings, it’s not expensive for a business growing revenue 20%+ with 40%+ margins.

Ackman’s new position is worth flagging. He’s now running a concentrated 11-stock portfolio and just added META as a top 5 position at around $660 per share. It’s now trading at $645 — modestly below his entry.

Current price: $644.86 | 52-week range: $479 – $795 | Since Q4 filing: -2.3%

4. Alphabet (GOOG + GOOGL) — 11 Investors, Two Share Classes

Combining both share classes, 11 distinct superinvestors bought or added Alphabet in Q4 2025 — the largest unique-investor count after MSFT and AMZN. Four opened fresh positions.

The Alphabet thesis is simple and powerful: the company is being valued as if AI kills Google Search. It won’t. Google Search is deeply embedded, generates ~$200B in annual revenue, and Google’s own AI (Gemini) is advancing rapidly. Meanwhile, YouTube is growing, Waymo is making real commercial progress, and Google Cloud is re-accelerating.

Christopher Davis, Francois Rochon, Harry Burn, William Von Mueffling, and Christopher Bloomstran all added significantly. Viking Global and two others opened new positions.

Current price: $298.52 | 52-week range: $140 – $349 | Where it sits in range: Upper third | Since Q4 filing: -4.6%

Chart 2: Where Are They Buying? (52-Week Range Positioning)

The further left a bar, the closer to the 52-week low — meaning superinvestors are buying at relatively cheap prices. Green = near lows. Red = near highs.

This chart is where the real opportunity analysis lives.

The Value Quadrant: High Conviction + Near 52-Week Lows

These are the stocks where smart money is buying and the price is near the low end of its annual range — suggesting you can get in at prices close to or better than what these managers paid.

Visa (V) — 9 Investors, Near-Bottom Range

9 superinvestors bought or added Visa in Q4 2025 — the fourth-highest in the dataset. More importantly, the stock is currently sitting at just 27% of its 52-week range, meaning it’s near its annual lows.

The bear case on Visa is always some variation of “fintech will displace it.” It hasn’t. Visa processes over $15 trillion in annual payment volume and has a virtually unassailable network effect. Two investors (AKO Capital and Stephen Mandel) opened fresh positions while seven others added.

At $317, Visa is -15% from its 52-week high of $373 and has pulled back -9.5% since the Q4 filing. You’re getting this at lower prices than the managers who filed.

Current price: $317.36 | 52-week range: $297 – $373 | Where it sits: 27% (near lows) | Since Q4 filing: -9.5%

Adobe (ADBE) — Near 52-Week Lows, 5 Managers Buying

Adobe is the most beaten-down quality name in the top conviction list. At $283, the stock is sitting at just 19% of its 52-week range — near its annual floor — and is -37% from its 52-week high of $452.

Five managers acted in Q4: Dodge & Cox, Lee Ainslie, Lindsell Train, Robert Olstein, and William Von Mueffling. One opened a fresh position.

The AI fear narrative (that generative image tools will make Adobe obsolete) has been priced in aggressively. But Adobe’s creative suite and PDF monopoly have proven remarkably sticky. The company is integrating AI into its products (Adobe Firefly) and continues to grow revenue at high single digits. At ~22x forward earnings, this is historical value territory for a business with 30%+ operating margins.

Current price: $283.62 | 52-week range: $244 – $452 | Where it sits: 19% (near lows) | Since Q4 filing: -19.0%

ADBE has continued to sell off since the Q4 filing. Five managers were buying it ~25% higher. You now have the opportunity to buy quality at a price they couldn’t.

Copart (CPRT) — 4 Managers, Near Annual Lows

Copart often flies under the radar because it operates in an unsexy business (salvage auto auctions), but it compounds like a dream — 20%+ ROE, asset-light, network effects, and no debt.

Four managers added in Q4 (AKO Capital, Chuck Akre, Torray Funds, Yacktman), and the stock is sitting at just 13% of its 52-week range — nearly at its annual floor.

If you want a high-quality compounder near 52-week lows with institutional backing, Copart deserves a spot on your watchlist.

Current price: $37.74 | 52-week range: $32 – $46 | Where it sits: 13% (near lows)

S&P Global (SPGI) — Duopoly Power at a Discount

5 managers bought or added SPGI including Chris Hohn, Glenn Greenberg, and Lindsell Train. The stock is -21% from its 52-week high and at 37% of its annual range.

SPGI and Moody’s are the world’s rating agency duopoly. They also own the S&P 500 index (Visa-like network effects on passive investment flows) and IHS Markit data. This is a toll-road business with irreplaceable infrastructure. It’s rarely cheap. Right now, it’s approaching cheap.

Current price: $452.36 | 52-week range: $381 – $576 | Where it sits: 37% | Since Q4 filing: -13.4%

Chart 3: Fresh Capital Deployment — New Positions Only

Bars = number of new investors who opened a fresh position. Line = stock’s performance since the Q4 filing. Stocks below the line are cheaper now than when they bought.

The Hidden Gems: Fresh Money Flowing Into Overlooked Names

Medline Inc. (MDLN) — 4 Simultaneous New Buys

This is the most interesting signal in the entire dataset.

Four elite managers all opened brand new positions in Medline (MDLN) in Q4 2025: Henry Ellenbogen (Durable Capital), Lee Ainslie (Maverick Capital), Stephen Mandel (Lone Pine Capital), and Viking Global Investors.

Think about what it means for four of the most sophisticated institutional investors in the world to independently arrive at the same new idea in the same quarter.

Medline is the largest privately-held medical supplies company in the U.S. — or was. It went public in 2024 at $42/share. These managers are essentially making a bet on the intersection of healthcare infrastructure demand, aging demographics, and a freshly public company that’s still being discovered. At $43.83 (+4.4% since filing), the stock hasn’t run. You’re still close to the IPO price.

Current price: $43.83 | 52-week range: $34.89 – $50.88 | Since Q4 filing: +4.4%

Thermo Fisher Scientific (TMO) — 3 New Buys, 20%+ Below High

Three managers opened fresh TMO positions in Q4: Daniel Loeb, Steven Romick, and Viking Global — joined by two more who added to existing positions.

Thermo Fisher is the picks-and-shovels play on life sciences — if biotech does research, they buy Thermo Fisher equipment, reagents, and services. The stock got crushed in 2024-2025 as COVID testing revenue faded and biotech funding dried up. At $502, it’s -22% from its 52-week high of $644.

Daniel Loeb and Steven Romick are value-oriented managers who rarely buy biotech infrastructure without a margin of safety. They see one here.

Current price: $501.97 | 52-week range: $385 – $644 | Where it sits: 45% | Since Q4 filing: -13.4%

Progressive Corp (PGR) — 3 New Buys, AI-Driven Underwriting

Progressive is quietly one of the best-run insurance companies in America, famous for using data analytics for underwriting long before anyone called it “AI.” Three managers opened new positions in Q4: Bruce Berkowitz, Daniel Loeb, and Viking Global.

Insurance isn’t exciting — until you see 20%+ returns on equity sustained for a decade. Progressive’s telematics and risk selection are industry-leading, and the auto insurance pricing cycle is favorable after years of rate increases. At $249, it’s -9% from its high.

Chart 4: Where Is Smart Money Flowing by Sector?

Technology dominates — but notice how much of the activity is in financial infrastructure (Visa, Mastercard, SPGI, ICE, AON, Fiserv), healthcare picks-and-shovels (Thermo Fisher, ISRG, GEHC), and select industrials (Ferguson, Copart, Union Pacific). This isn’t pure growth chasing — it’s value-hunting across multiple sectors.

The Stocks Already Pricing In the Good News (Proceed With Caution)

Not every smart money buy is a current opportunity. These stocks have already moved substantially since the Q4 filings:

These are great businesses and the conviction behind them is real — but if you’re buying after a 10-12% run from already elevated prices, you’re paying more than the managers who tipped you off. TSM especially — at 80% of its 52-week range and +11.5% since filing — has meaningfully appreciated. The AI chip thesis is compelling, but the entry is less attractive today.

The Watchlist: My Takeaways

If I’m building a watchlist from this data, these are the names where high institutional conviction meets attractive relative pricing:

One Final Thought

13-F analysis is a lagging indicator — by definition, you’re looking at what managers held 45-90 days ago. Positions can change. But the signal isn’t about timing — it’s about identifying where institutional intelligence has clustered.

When 16 of the world’s best investors add to the same stock in the same quarter, and that stock has since gotten cheaper, that convergence is worth taking seriously.

The market has given you lower prices than the smartest money in the world paid. What you do with that is up to you.

Data sourced from Dataroma.com Q4 2025 13-F filings. All prices as of early March 2026. This is not financial advice. Past superinvestor activity does not guarantee future returns. Always do your own research before making investment decisions.

If this was useful, consider sharing it. The next edition will dig deeper into the individual position sizes and portfolio concentration — where managers are putting their largest bets.

.

The Real Story: Membership and Digital Are Accelerating

What matters most in Costco's results isn't the $0.03 beat on EPS or the $350 million revenue beat. It's the underlying momentum in the business model that makes Costco arguably the most resilient consumer-facing company in America today.

Comparable sales growth of 7.4% may sound pedestrian in isolation, but the regional breakdown tells a much more interesting story. U.S. comp sales advanced 5.9% (adjusted 6.4%), while Canada powered ahead with 10.1% growth, and the International segment posted 13.0% comp sales growth. These aren't warehouse club numbers—these are high-single-digit growth rates across every major geography, suggesting that Costco's value proposition remains sticky regardless of macro conditions.

But the real growth engine is digital. Digital-enabled sales surged 22.6% in the quarter, now representing a material portion of the company's transaction volume. This is critical context: Costco isn't growing faster because it's lowering prices or cutting margins to defend share. It's growing faster because members are using Costco in more ways—visiting warehouses, ordering online, mixing physical and digital experiences. That omnichannel capability is exactly what's powering the 13.9% year-over-year EPS growth.

Membership: The Billion-Dollar Recurring Revenue Stream

Costco's real profit engine isn't selling groceries or televisions—it's selling memberships. In the quarter, membership fee income hit $1.36 billion, up 13.6% year-over-year. That's a recurring revenue stream growing faster than the company's core retail business, with better economics than selling physical goods.

Think about what that means: Costco added enough net new members and saw enough upgrades to Executive memberships to drive that fee revenue growth in a mature market. This isn't a growth story borrowed from emerging markets or new geographies—this is a story of deepening penetration in a saturated domestic market, with members voting with their wallets that the membership is worth renewing

.

Operating Leverage and Margin Stability

One of the most overlooked aspects of Costco's business is operating margin stability. In Q2, the company maintained 3.7% operating margins despite revenue growing at 9.1% year-over-year. This isn't a company squeezing margins to make the numbers; it's a company that has optimized its cost structure so thoroughly that it can invest in digital, expand its footprint to 924 warehouses worldwide, and still deliver steady profitability.

The operating income picture reinforces this: Q2 operating income of $2.61 billion is up from $2.29 billion in the prior year quarter—an 13.8% increase that matches the EPS growth rate. Costco's entire value chain—from sourcing to logistics to warehouse operations—is functioning at a high level of efficiency.

The Warehouse Count Matters More Than You Think

Costco now operates 924 warehouses worldwide, with 634 in the U.S. and Puerto Rico, 114 in Canada, 42 in Mexico, and 37 in Japan. In a capital-intensive business, the company has been disciplined about expansion, opening only where unit economics pencil out. The fact that it's maintaining strong same-store sales while expanding the base suggests that new warehouse openings are filling white space rather than cannibalizing existing locations.

Through the first 24 weeks of fiscal 2026, Costco deployed $2.82 billion in capital expenditures while generating $7.68 billion in operating cash flow. That's a positive working capital story that gives management confidence to continue reinvesting in the business.

Why The Stock Sold Off (And Why That Might Be Wrong)

COST is trading at an elevated valuation multiple—the market has been pricing in perfect execution for years. A beat on earnings, while good, isn't shocking for a company that's been executing consistently. The stock's post-earnings decline reflects not disappointment in Costco's results, but rather the reality that the bar for a positive surprise has been set very high.

However, there's something important in these results that markets might be underappreciating: the resilience of the membership base during a period of macro uncertainty. The 13.6% growth in membership fee revenue happened in the same economy where consumer credit is at stress levels and some retailers are guiding down. That Costco is adding members and pushing more of them into the higher-margin Executive tier suggests that the business has untapped pricing power.

Looking Forward

Costco doesn't provide forward guidance, but the trends embedded in these results are clear. Digital acceleration is driving higher attachment rates without compromising warehouse economics. Geographic diversification is reducing dependence on U.S. comps. Membership fee growth is outpacing merchandise sales growth, indicating a shift towards higher-quality, stickier revenue.

The market will likely remain skeptical of COST's valuation until the macro environment shows more explicit signs of strength. But in a world where consumer resilience is suspect and execution risk is everywhere, Costco's ability to grow comps in the high single digits while expanding membership fee revenue and maintaining operating margin stability is increasingly rare and increasingly valuable.

For investors focused on quality of earnings, consistency of execution, and recession-resistant revenue streams, the membership machine is still the best story in retail.

📊 Revenue Keeps Compounding

Wix grew revenue 14% year-over-year to $524M in Q4, capping a full year at $1.99B — up 13% for 2025. That's steady, not spectacular. But the bookings picture is more encouraging: total Q4 bookings hit $535M (+15% YoY), and ARR reached $1.84B, also up 14%.

The revenue trend matters here. Five straight quarters of double-digit growth, with Q4 2025 marking the strongest in the streak at $524M — up from $460M a year ago.

🏗️ Partners Is the Fastest Engine

The segment breakdown tells the real story of Wix's transformation. For full-year 2025:

• Creative Subscriptions: $1.41B (+11% YoY) — the core SMB business, steady

• Partners: $750M (+23% YoY) — agencies and freelancers building on Wix

• Business Solutions: $583M (+18% YoY) — payments, bookings, ecommerce tools

• Transactions: $255M (+19% YoY) — take-rate on commerce flowing through the platform

The Partners segment growing at 23% — nearly twice the rate of core subscriptions — signals a structural shift. Wix is becoming a platform businesses build on, not just a tool individuals use. That changes the retention profile, the contract size, and the long-term monetization ceiling.

🎯 EPS Beat Was the Headline

Revenue came in essentially in line with expectations ($524M vs. $527M estimated). But the real beat was on profitability:

• Non-GAAP EPS: $1.81 vs. $1.47 estimated — a 23% beat

• Adjusted Operating Income: $81M vs. $77M estimated — beat by 6%, 15.5% margin

• Free Cash Flow: $156M in Q4, $573M for the full year — 30% FCF margin

This is a company with improving operating leverage. Revenue growing at 13-14% while EPS and FCF grow faster means the margin story is intact even as Wix invests heavily in AI.

🔮 2026 Outlook: Confident, Not Cautious

Management's 2026 guidance was straightforward: mid-teens revenue and bookings growth across both Q1 and the full year. FCF margin guided to the "low-to-mid 20% range" — a step down from the 30% delivered in 2025, reflecting accelerated AI investment.

The strategic numbers are more interesting than the guidance range:

• Base44 ARR: $100M — reached nine months after acquisition. CEO Abrahami explicitly called this a "new and much larger" opportunity separate from the core Wix.com business

• $2B share buyback authorized — the largest in company history, majority to be completed by end of 2026

• $250M private placement — led by Durable Capital Partners, capital earmarked to accelerate AI development

• $20B+ in future bookings projected from existing Wix.com users over the next decade, before any Base44 contribution

⚡ The Bottom Line

What does this quarter actually signal? Wix is threading a needle most software companies can't: deploying capital into AI while simultaneously returning capital to shareholders. The $250M raise + $2B buyback combo isn't contradictory — it's a statement that management believes the AI investments will generate returns that justify both.

The risk is execution. Wix Harmony and Base44 are bets that AI-native creation tools become the default for website builders over the next 3-5 years. If that plays out, the $20B future bookings projection starts to look conservative. If AI commoditizes website creation entirely, Wix's core subscription business faces structural headwinds.

For now, the numbers say the bet is working.

Until next time,

Qarp Fund

Clean Beats on Every Line

Q4 revenue came in at $836 million, up 16% year-over-year and $28 million ahead of Wall Street's estimate. Non-GAAP EPS of $2.06 beat the $1.94 consensus by $0.12 — a meaningful margin for a company that typically guides conservatively. The bigger beat came in guidance: FY2027 revenue is guided to $3.585–$3.600 billion, roughly $130 million above what the Street was expecting.

Revenue Growth Has Reaccelerated

Veeva grew at 16% in Q4 FY2026 — consistent with the pace of the last four quarters. What matters here isn't just the absolute growth rate, but the fact that it's reaccelerating after a slower period in FY2024. The sequential quarterly progression has been remarkably smooth: $759M → $789M → $811M → $836M. This kind of consistent step-up indicates a business where the pipeline is converting reliably, not lumpy deal-timing dependent.

The Long Arc: From $2B to $6B

Looking at the multi-year picture, Veeva's revenue trajectory has gone from 9% growth in FY2024 to 16-17% in FY2025-2026, and the FY2027 guide implies 12% growth at the midpoint — with management reaffirming a $6 billion annual revenue target by FY2030. For context, FY2023 revenue was $2.16 billion. Getting to $6 billion in seven years requires a ~16% CAGR. The Vault CRM migration, new AI products, and geographic expansion are the levers to get there.

The Revenue Mix That Makes This Business Exceptional

Veeva's subscription revenue — $707.7 million in Q4, 84.7% of total — carries an 86.5% gross margin. That's an exceptional number in enterprise software. Professional services fills out the rest at 15%, lower-margin but important for implementation and expansion. The flywheel: every new Vault CRM or Vault Clinical customer drives professional services revenue during implementation, which then converts to recurring, high-margin subscription revenue for years. Full-year subscription revenue grew 17% — the fastest rate in three years.

FY2027 Guidance: Steady Acceleration

Management guided FY2027 to $3.585–$3.600 billion in revenue with non-GAAP EPS of approximately $8.85. That's +9% EPS growth on +12% revenue growth — implying some margin investment, likely in Veeva AI and international expansion. Q1 FY2027 is guided to $855–$858 million, which will be the first official data point showing whether Vault CRM momentum accelerates further into the new fiscal year.

What Wall Street Is Watching Now

Veeva has always been a company that earns its premium multiple through execution consistency. This quarter delivered that. The key question for the next 12 months: how fast does Vault CRM land the remaining top-20 biopharmas (currently 7 of 20 fully committed), and when does Veeva AI start showing up in ASP expansion? The answers will determine whether the stock re-rates further or consolidates near current levels.

Veeva reports Q1 FY2027 in June. Watch subscription revenue growth rate and Vault CRM live customer count for leading indicators of whether the FY2027 guidance proves conservative.

The Numbers Were Clean

Broadcom beat on every metric that matters. Revenue came in at $19.31 billion, up 29% year-over-year, against a Wall Street consensus of $19.1 billion. Non-GAAP EPS of $2.05 topped the $2.02 estimate. But the real beat was in guidance: Q2 revenue guided to $22.0 billion versus the $20.56 billion consensus — a $1.44 billion upside surprise that sent the stock up ~5% in after-hours trading.

Revenue Has Been Compounding Steadily

Broadcom's total revenue growth re-accelerated meaningfully this quarter. After several quarters in the 20–22% YoY range, Q1 FY2026 printed +29% — driven almost entirely by AI semiconductor demand outpacing the rest of the business. The trajectory heading into Q2's $22 billion guide suggests the growth rate itself is still climbing.

AI Revenue More Than Doubled

The standout number: AI semiconductor revenue hit $8.4 billion in Q1 FY2026, up 106% year-over-year. That's not a rounding error — AI revenue literally more than doubled. And Q2 guidance calls for $10.7 billion, implying roughly 143% YoY growth for the current quarter. The blue bar in the chart below represents Q2 guidance, not actuals — which makes it even more striking.

Two Very Different Business Segments

Broadcom's business has two legs: Semiconductor Solutions and Infrastructure Software. In Q1 FY2026, those two legs moved in completely opposite directions. Semiconductor Solutions grew 52% year-over-year to $12.5 billion, almost entirely driven by AI chip demand. Infrastructure Software — the legacy VMware business acquired in 2023 — grew just 1% to $6.8 billion. The strategy is playing out exactly as Hock Tan designed: use the software cash flow to fund the AI buildout.

The Q2 Guidance Is What Changes the Math

Guiding to $22 billion for Q2 — with AI semiconductor revenue expected at $10.7 billion — is the kind of forward guidance that forces analysts to rip up their models. Prior Wall Street estimates for full-year FY2026 were clustering around $72–75 billion. With Q1 at $19.3B and Q2 guided at $22B, that full-year number is almost certainly going higher. Adjusted EBITDA margins are expected to hold steady at ~68%, meaning every incremental revenue dollar is highly profitable.

What Wall Street Is Focused On Now

The $100 billion forecast is the most significant thing Hock Tan has ever said publicly about Broadcom's AI business. That's not a vague aspiration — it's a CEO with a track record of disciplined capital allocation making a specific directional claim about a specific revenue line. If AI revenue hits $100 billion in fiscal 2027, that's roughly five times what Broadcom generated in AI chips in all of FY2025. The math requires continued acceleration from all six hyperscaler customers, expanding silicon content per cluster, and Broadcom's Ethernet networking revenue growing to ~40% of total AI chip revenue. None of that is guaranteed. But the order book is suggesting it's on track.

Broadcom reports next quarter in June. Between now and then, watch for any announcements from hyperscaler customers about their capex plans — those will be the leading indicator for whether the $100 billion 2027 forecast is tracking.

📈 Eight Quarters of Unstoppable Growth

Sea's revenue trajectory is remarkable. From $3.73B in Q1 2024 to $6.85B in Q4 2025 — that's 84% growth in two years for a company already operating at scale across Southeast Asia, Latin America, and beyond.

• Q4 2025 Revenue: $6.85B (+38.4% YoY)

• Full Year 2025: $22.9B (+36.4% YoY)

• Sequential acceleration: Each of the last four quarters has hit a new record

The $400M revenue beat — against a $6.45B estimate — reflects Shopee's dominance in SE Asia e-commerce and Monee's explosive growth in digital finance. This is not a company slowing down.

🎯 The Scorecard: Revenue Win, EPS Loss

Here's the split verdict that drove the selloff:

• Revenue: $6.85B vs. $6.45B estimate → Beat by $400M

• EPS: $0.63 vs. $0.66 estimate → Missed by $0.03

A $0.03 EPS miss triggered a 12% stock drop on a $400M revenue beat. That math only makes sense if investors were expecting Sea to prove it could scale profitably — and gross margin slipping from 44.55% to 43.76% raised enough doubt to spook the market.

Stock closed down 12.1% on March 3, 2026.

🏪 Three Engines, One Machine

Sea isn't a one-trick pony. All three business segments grew more than 35% year-over-year:

• Shopee (E-Commerce): $4.30B (+35.8%) — 62.8% of total revenue

• Monee (Digital Finance): $1.10B (+54.3%) — the fastest-growing segment

• Garena (Gaming): $0.70B (+35.1%) — a genuine comeback after years of decline

Monee's 54.3% growth is the number to watch. A $9B+ loan book, 20+ million new borrowers in 2025, and Adj. EBITDA now exceeding $1B annually. Sea is quietly becoming one of Southeast Asia's largest digital lenders.

💰 The Profit Turnaround Wall Street Is Forgetting

Just five quarters ago, Sea was losing money. In Q1 2024, net income was -$24 million. By Q4 2025, it's $397 million. That's not a trend — that's a transformation.

• FY2025 Net Income: $1.58B (vs. $444M in FY2024 — a 255% jump)

• FY2025 Adj. EBITDA: $3.4B (+75% YoY)

• Operating cash flow Q4: $1.48B

• Cash on hand: $6.42B as of Dec 31, 2025

The market is focused on a $0.03 EPS miss. The underlying reality is a company that generated $1.58 billion in net profit last year — up from near-zero two years ago.

🔑 The Numbers Behind the Numbers

⚡ The Bottom Line

Sea's Q4 2025 was a case of the market penalizing perfection for not being perfect enough. Revenue grew 38%. Every segment accelerated. Net income hit $397M. And yet a $0.03 EPS shortfall sent the stock down 12%.

The bears will point to margin pressure and wonder whether Sea can sustain profitability as it invests in Shopee's 2026 expansion. The bulls will note that $22.9 billion in annual revenue, a $9B loan book, and 633 million Garena users don't happen by accident.

For 2026, Forrest Li is targeting Shopee GMV growth of ~25% and Adj. EBITDA "no lower than 2025" — meaning at least $3.4B in earnings power. With $6.4B in cash and three engines firing simultaneously, Sea's flywheel is very much intact.

Until next time,
Qarp Fund

📊 Sales Growth Remains Solid

AutoZone posted $4.27 billion in net sales for Q2 FY2026 (the 12-week period ending February 14, 2026), an increase of 8.1% year-over-year. That's the kind of steady growth you'd expect from a company selling parts for the nearly 300 million cars on American roads.

But Wall Street was looking for $4.35 billion — and the $79 million gap is what drove the selloff.

• Net Sales: $4.27B (+8.1% YoY)

• Net Income: $468.9M (down from $487.9M a year ago)

• YTD Revenue: $8.9B through the first 24 weeks of fiscal 2026

Worth noting: Q4 FY2025's enormous $6.24B reflects AutoZone's longer 16-week fiscal fourth quarter — not a sudden surge in business.

🎯 EPS Beat, Revenue Miss — Market Chose the Miss

Here's the split verdict from Q2:

• EPS: $27.63 vs. $27.41 estimate → Beat by $0.22

• Revenue: $4.27B vs. $4.35B estimate → Missed by $79M

The EPS beat matters less when gross margins are shrinking. Net income fell to $468.9M from $487.9M — a $19M drop year-over-year despite 8% revenue growth. The market read that as a signal that AutoZone's profitability engine is under stress.

Stock closed down 6.7% on March 3, 2026.

🏪 The Cars Are Coming In. Comps Are Growing.

The underlying demand story is healthy. Comparable store sales (SSS) grew across all geographies:

• Domestic: +3.4% (despite winter storms in late January and early February)

• International (constant currency): +2.5%

• Total Company (constant currency): +3.3%

Management flagged winter storms as a meaningful headwind in the back half of Q2. Auto parts demand is highly weather-correlated — storms suppress DIY repair activity. The fact that comps stayed positive through those disruptions speaks to the durability of AutoZone's customer base.

The international headline number looks eye-popping at +17.1% — but that's a currency translation effect, not operational outperformance. In constant currency, it was a solid but unspectacular +2.5%.

📉 Margin Compression: Blame the Accounting, Not the Business

This is the number that spooked investors: gross margin fell to 52.5%, down 137 basis points year-over-year.

But here's the key detail: 138 of those 137 basis points came from a single non-cash LIFO charge.

LIFO (Last In, First Out) inventory accounting means that when parts costs rise, AutoZone's cost of goods sold reflects the higher-priced inventory first — even if those parts haven't actually been sold yet. It's an accounting methodology, not a cash expense. Excluding LIFO, gross margins were essentially flat year-over-year.

The business is fine. The accounting treatment is making it look worse than it is. But GAAP is GAAP, and analysts aren't ignoring the trend.

🌎 7,774 Stores and Still Expanding

AutoZone opened 64 net new stores in Q2, staying firmly on track for its full-year target of 350–360 new locations globally.

The US footprint dominates at 6,709 stores (86% of total), but Mexico (913 stores) and Brazil (152 stores) represent the growth runway. International expansion is the long game — and AutoZone is playing it methodically.

One flag worth watching: inventory per store grew 13.1% year-over-year. That reflects deliberate stocking decisions in anticipation of demand — but it also means capital tied up in shelves, contributing to the LIFO charge problem.

🔑 The Numbers Behind the Numbers

⚡ The Bottom Line

AutoZone's Q2 FY2026 was a tale of optical vs. operational performance. The business grew 8%. Comps stayed positive through weather disruptions. New stores opened on schedule. And a $310.8M share buyback program is steadily reducing the share count.

But a non-cash accounting charge made margins look terrible, a $79M revenue shortfall disappointed analysts, and the stock got punished accordingly.

The bears will point to the margin trend and wonder if the LIFO charges keep coming. The bulls will note that ex-LIFO, the business is performing as expected — and that a shrinking float and disciplined expansion point toward EPS recovery.

With $1.4 billion of buyback authorization remaining and a store count approaching 8,000, AutoZone's flywheel is intact. Whether the stock recovers depends on whether the LIFO headwind becomes the story — or just a footnote.

Until next time,
Qarp Fund

📊 Revenue: Six Straight Quarters of Growth

GitLab closed Q4 FY2026 with $260.4M in revenue (+23% YoY), beating the $252.2M estimate by $8.2M. Full-year FY2026 revenue hit $955.2M (+26% YoY) — just shy of the $1 billion annual mark.

• GitLab delivered a clean Q4 beat. Revenue, EPS, and gross margins all came in above estimates. The problem: FY2027 guidance.

  • Revenue beat: $260.4M vs. $252.2M est ✅

  • Non-GAAP EPS beat: $0.30 vs. $0.23 est ✅

  • FY27 EPS guide: $0.76–$0.80 vs. $1.05 consensus ❌ (25%+ miss)

  • FY27 Revenue guide: $1.10–$1.12B vs. $1.12B est (slight miss)

  Management is making a deliberate choice: invest heavily in the Duo Agent Platform, compress near-term margins, and bet on the AI developer tools wave. Reasonable strategy. Markets wanted more profitability now.

  🔮 FY2027 Outlook: Revenue On Track, Margins Under Pressure

  • Q1 FY2027 Revenue: $253–$255M (seasonal step-down)

  • Full Year FY2027 Revenue: $1.10–$1.12B (~16% growth)

  • Full Year FY2027 EPS: $0.76–$0.80 (vs. $1.05 est — big miss)

  • $400M buyback: First ever — signals long-term confidence

  CEO Bill Staples: “GitLab sits at the heart of how enterprises build and deliver software.” The Duo Agent Platform aims to automate developer workflows — a direct play on the AI coding wave that’s reshaping enterprise software.

  ⚡ The Bottom Line

  GitLab had a genuinely strong Q4. The $1B ARR milestone is meaningful. The $400M buyback shows management confidence. Enterprise customer growth at the $1M+ tier is accelerating.

  But the 25% EPS guidance miss is hard to ignore. Markets are pricing in profitable growth, and GitLab is choosing investment over profitability for FY2027. The question: does the Duo Agent Platform accelerate the growth story — or is this a margin drag that delays the payoff?

  Watch the net retention rate. 118% is solid. If Duo drives it above 120% in FY2027, the AI investment is working. If it slips, the mid-market and SMB pressure is the real story.

  • Follow @qarpfund for weekly earnings analysis

  Until next time,

  Qarp FundQ4 Revenue: $260.4M vs. $252.2M est (+$8.2M beat)

• Full Year FY2026: $955.2M (+26% YoY)

• Gross Margin: 89% non-GAAP — world-class software economics

• RPO: $1.1B total (+20% YoY), O $719.4M (+24% YoY)

Six consecutive quarters of sequential growth. The RPO acceleration signals future revenue is being locked in ahead of schedule.

🎯 Enterprise Customers: The $1M+ Cohort Is Accelerating

GitLab added the largest number of million-dollar ARR customers in company history in Q4. Enterprise platform consolidation is working.

• $5K+ ARR customers: 10,682 (+8% YoY)

• $100K+ ARR customers: 1,456 (+18% YoY)

• $1M+ ARR customers: 155+ — record additions

The acceleration at the top of the funnel is exactly what a platform consolidation story looks like. Enterprises are replacing multiple dev tools with GitLab as their single DevSecOps platform.

✅ Q4 Beat Sheet — But the Forward Guidance Tells a Different Story

📊 Revenue: Eight Straight Quarters of Growth

Revenue came in at $1.31 billion (+23% YoY), beating the $1.30B consensus by $10 million. But the quarterly number barely tells the story — the trajectory does.

• Revenue: $1.31B vs. $1.30B est (+$10M beat)

• Subscription Revenue: $1.24B (+23% YoY)

• Full-Year FY2026 Revenue: $4.81B (+22% YoY)

• Gross Margin: 79% GAAP, 8P — END_REV

CrowdStrike has now strung together eight consecutive quarters of sequential revenue growth. From $921M in Q1 FY2025 to $1.31B in Q4 FY2026 — a 42% increase in just two years.

🎯 ARR Hits $5.25B — The Real Story Is Net New ARR +47%

ARR metrics are where CrowdStrike shows its true health, and Q4 FY2026 was historic on every line.

• Ending ARR: $5.25B (+24% YoY)

• Net New ARR: $331M (+47% YoY) — company record

• Full-Year Net New ARR: $1.01B — first $1B year

• Falcon Flex ARR: $1.69B (+12END_ARR

The +47% acceleration in net new ARR is the number that matters most. The July 2024 outage hangover is officially gone. As CEO George Kurtz put it: “FY26 will go down in our history books as CrowdStrike’s best year yet.”

✅ Q4 FY2026: A Clean Sweep

CrowdStrike beat on every metric simultaneously — including a historic first.

• Revenue: $1.31B vs. $1.30B est ✅

• Adj. EPS: $1.12 vs. $1.10 est ✅

• Free Cash Flow: $376M vs. $341M est ✅

• Adj. Net Income: $289M vs. $284M est ✅

• ARR: $5.25B vs. $5.

That last one deserves a moment. The pivot to GAAP profitability while maintaining 23% revenue growth is not a small feat.

🔮 FY2027 Guidance: $6B ARR Is the Target

• Q1 Revenue: $1.36B guide vs $1.35B est ▲

• Q1 EPS: $1.06–1.07 vs $1.05 est ▲

• FY27 Revenue: $5.87–5.93B (in-line)

• FY27 ARR: $6.47–6.52B ND_GUIDE

CFO Burt Podbere: “We have strong conviction to once again raise our FY27 ARR outlook.”

⚡ The Bottom Line

The July 2024 outage was supposed to be an existential threat. Eighteen months later, CrowdStrike has printed a record quarter on every forward-looking metric that matters.

Net New ARR at +47% YoY means the pipeline is full. Falcon Flex ARR at +120% YoY means the platform bet is working. $1.24B in annual free cash flow means CrowdStrike is now a cash machine.

The 5% after-hours drop? Markets priced in perfection, management delivered excellence with prudence. Watch for net new ARR in Q1 FY2027 — if +47% momentum continues, the FY2027 revenue number will look low by summer.

• Follow @qarpfund for weekly earnings analysis

Until next time,

Qarp Fund

New here? Read Week 2 of my options trading journey to see how I navigated my first assignment with LULU and generated $707 in realized gains.

The Week of Strategic Execution

Week 3 focused on executing planned strategies while building new systematic positions for future income. The week delivered solid realized profits from closed positions, particularly the RDDT short strangle, while establishing a foundation of new weekly positions across multiple quality names.

The result? Strong realized performance from closed trades while positioning for continued systematic income generation.

By The Numbers: Week 3 Realized Performance

The Trades: Closed Positions and New Systematic Builds

RDDT Trade-Off: Solid Profit with Missed Upside

The RDDT short strangle established in Week 2 reached its conclusion with mixed results - good realized profits but significant missed upside.

RDDT Short Strangle - CLOSED POSITIONS:

Stock profit: $2,539.97 (200 shares × ($121 - $108.30))

The Reality Check: RDDT closed at $139.15 on expiration day. By getting called away at $121, I left approximately $3,630 in additional gains on the table (200 shares × $18.15). This illustrates the fundamental trade-off of covered calls: steady income with capped upside.

Subscribe now

Other June 20th Closures

Completed Expiration Trades:

Both positions expired as planned, generating solid income through time decay on quality underlying stocks.

New Systematic Positions (Still Open)

While not yet realized, Week 3 established systematic weekly positions across multiple quality names:

New Weekly Positions (6/27 Expiration) - OPEN:

These positions represent the systematic scaling approach but won't count as realized profits until closed.

Position Management: Execution and Learning

1. Accepting Assignment Trade-Offs

The RDDT call assignment demonstrates the core covered call principle: we captured solid profits ($3,495) but gave up significant additional upside ($3,630). This wasn't a mistake - it's the inherent nature of the strategy.

2. Systematic Position Building

The five new weekly positions show the evolution from single-trade focus to systematic income campaigns. While still open, all are currently profitable with time decay working in our favor.

3. Quality Stock Selection

Choosing ABNB, AMD, META, and UBER reflects focus on established, profitable companies with strong fundamentals - reducing the risk of adverse movements.

4. Diversified Timeframes

Maintaining both weekly expirations and longer-term positions (like the July CPRT positions) creates multiple income streams with different risk profiles.

Current Portfolio Status

Recently Closed Positions (Realized):

• RDDT: 200 shares called away, short strangle completed

• AMAT: Short call expired worthless

• UBER: Short call expired worthless

Active Weekly Positions (6/27 Expiration): All five new positions are currently showing unrealized profits as time decay works in our favor.

Stock Holdings for Future Income:

• AMAT: 100 shares (available for covered calls)

• ASML: 100 shares (strong position)

• CPRT: 400 shares (enhanced income potential)

• LULU: 100 shares (recovery position)

• RDDT: 100 shares (remaining exposure at $135.12 cost)

Total Stock Holdings: 700 shares across 5 quality companies

What's Working and What's Challenging

Successful Execution:

• Systematic approach: Building consistent weekly positions across quality names

• Disciplined closes: Accepting assignments and expirations as planned

• Quality focus: Strong underlying companies providing better outcomes

• Diversification: Multiple positions reducing single-stock dependency

Areas for Improvement:

• Strike selection: RDDT $121 calls capped significant upside

• Rolling decisions: Could explore rolling up and out on winning positions

• Position sizing: Optimizing allocation based on volatility and conviction

• Timing: Earlier action on in-the-money positions might preserve more upside

Lessons from Week 3

Key Takeaways:

1. Covered calls cap upside: RDDT's rise to $139 vs. $121 assignment shows the trade-off

2. Systematic building works: Five quality positions established with good initial results

3. Quality matters: Strong companies provide better option premiums and stability

4. Diversification helps: Multiple positions reduce impact of any single outcome

5. Discipline pays: Following the plan generates consistent results even if not optimal

Strategic Insights:

The week reinforced that systematic options income trading is about consistent execution rather than trying to time perfect entries and exits. The RDDT trade generated good profits despite leaving money on the table - this is the nature of covered call strategies.

Looking Ahead: Week 4 Focus

Immediate Priorities:

• Manage 6/27 expirations: Five positions currently profitable

• Deploy 700-share stock portfolio: Enhanced covered call opportunities

• Continue systematic approach: Build next week's income positions

Strategic Development:

• Refine strike selection: Balance premium collection vs. upside retention

• Optimize position sizing: Based on volatility and conviction levels

• Enhance rolling strategies: Explore up-and-out rolls on winning positions

The Reality of Systematic Trading

Week 3 demonstrated both the benefits and limitations of disciplined options income trading:

The Good: $3,861 in realized profits from systematic execution of planned strategies across quality names.

The Learning: RDDT showed how covered calls work in practice - good profits with capped upside when stocks continue rising.

The Foundation: Five new systematic positions established across quality companies, setting up future income opportunities.

This week reinforced that successful options income trading isn't about perfect execution - it's about consistent application of sound principles across quality underlying assets.

Next week: Managing the current systematic positions while continuing to build the weekly income approach.

Disclaimer: This is educational content documenting actual trades. Options trading involves significant risk and is not suitable for all investors. Assignment requires substantial capital and can result in significant losses. Past performance does not guarantee future results. Always do your own research and consider your risk tolerance.

UnitedHealth Group faces a challenging 2025 after delivering strong 2024 results but experiencing unexpected medical cost pressures in Medicare Advantage. Despite generating over $400 billion in revenue in 2024, the company has revised its 2025 earnings guidance downward due to heightened care activity in its Medicare business. However, UNH's diversified business model through Optum continues to provide stability and growth opportunities.

Key Financial Highlights (2024)

Business Model Strength

UnitedHealth Group operates through two complementary segments:

UnitedHealthcare (~75% of revenue): Provides health benefits across commercial, Medicare, Medicaid, and international markets, serving over 53 million people globally.

Optum (~25% of revenue): Delivers healthcare services through three divisions:

• Optum Health: Care delivery with ~105 billion in revenue

• Optum Rx: Pharmacy benefits with over $130 billion in revenue

• Optum Insight: Technology and analytics with $19 billion in revenue

Subscribe now

Key Performance Metrics Analysis

Return on Invested Capital (ROIC)

UNH's ROIC declined to 8.0% in 2024 from 13.8% in 2023, primarily due to elevated medical costs and one-time impacts. Historically, the company has maintained strong ROIC above 13%, demonstrating efficient capital allocation.

Revenue Growth

The company achieved consistent revenue growth, with a 10-year CAGR of 9.7%. Revenue increased from $157.1B in 2015 to $400.3B in 2024, showcasing the company's market expansion and acquisition strategy.

Free Cash Flow Generation

Despite 2024 challenges, UNH generated $20.7B in free cash flow. The 10-year average FCF is approximately $16.8B, with peak generation of $25.7B in 2023.

Net Margins

Net margins compressed significantly in 2024 to 3.6% due to elevated medical costs in Medicare Advantage. Historical margins averaged around 5-6%, which management expects to restore as cost pressures normalize.

Debt Management

Net debt increased to $51.6B in 2024 ($76.9B total debt minus $25.3B cash). The debt-to-equity ratio of 77.3% reflects the company's leveraged growth strategy while maintaining investment-grade credit ratings.

Valuation Analysis

Current Valuation Metrics

Peer Comparison

UNH trades at a discount to many peers despite its market leadership and diversified business model, suggesting potential value for long-term investors.

2025 Outlook and Challenges

Revised Guidance

• Net Earnings: $24.65-$25.15 per share (down from $28.15-$28.65)

• Adjusted Earnings: $26.00-$26.50 per share (down from $29.50-$30.00)

• Revenue: $450-$455 billion

• Operating Cash Flow: $32-$33 billion

Key Risk Factors

1. Medicare Advantage Pressures: Elevated medical costs and star rating challenges

2. Regulatory Oversight: Increased CMS auditing of Medicare Advantage contracts

3. Competition: Market share pressure from other major insurers

4. Cyber Security: Ongoing costs from 2024 Change Healthcare cyberattack

Growth Opportunities

1. Medicare Advantage Market Share: Potential to gain members as competitors struggle

2. Optum Expansion: Continued growth in care delivery and technology services

3. Commercial Insurance: Strong growth in self-funded employer plans

4. International Markets: Expansion opportunities in global healthcare services

Investment Thesis

Bull Case

• Market Leadership: Dominant position in Medicare Advantage with scale advantages

• Diversified Revenue: Optum provides stability and higher-margin growth

• Cash Generation: Strong FCF supports dividend growth and share buybacks

• Valuation Opportunity: Stock trades at attractive multiples relative to historical norms

• Competitive Moat: Integrated healthcare model difficult to replicate

Bear Case

• Medicare Headwinds: Ongoing pressure from CMS rate updates and star ratings

• Medical Cost Inflation: Rising healthcare costs pressuring margins

• Regulatory Risk: Potential for increased government intervention

• Execution Risk: Challenge of integrating Optum acquisitions and delivering synergies

Technical Analysis

The stock has declined from highs near $550 in 2023 to current levels around $311, representing a significant correction. Key support levels exist around $300, while resistance is at $350-$375. The dividend yield of 2.8% provides downside support for income-focused investors.

Conclusion

UnitedHealth Group remains the undisputed leader in U.S. healthcare, with an unmatched scale and diversified business model through Optum. While 2025 presents near-term challenges in Medicare Advantage, the company's long-term fundamentals remain strong.

The current valuation presents an attractive entry point for long-term investors willing to navigate near-term volatility. UNH's ability to generate substantial free cash flow, maintain market leadership, and expand through Optum positions it well for long-term value creation despite current headwinds.

Rating: BUY
Price Target: $380-$420 (12-month)
Risk Level: Moderate

Investors should monitor quarterly results for evidence of Medicare cost stabilization and Optum growth acceleration.

Disclaimer: This analysis is for informational and educational purposes only and should not be considered as personalized investment advice.

The Week That Tested My Strategy

This week was a masterclass in both the rewards and risks of systematic options income trading. While I collected over $2,370 in net options premium across multiple positions, I also experienced my first significant assignment of the year when Lululemon (LULU) crashed through my put strike.

The result? A week that perfectly illustrates why options income trading requires both offensive strategy and defensive trade management.

By The Numbers: Week 2 Performance

Subscribe now

The Trades: A Multi-Pronged Approach

The Weekly Income Strategy

June 13th Expiration Results

*Assignment creates $255.75 effective cost basis (after premium)

The Assignment: LULU Put Strategy

Here's where the week got interesting. I sold a $260 put on Lululemon for $424.32 in premium - a juicy 1.6% return for just 4 days.

The Risk: LULU dropped to $239.11 at expiration, forcing assignment of 100 shares at $260.

The Reality Check: While I'm now holding LULU shares with an unrealized loss of $1,664, my effective cost basis is $255.75 after the premium collected. This puts me in position to either sell covered calls against the shares or wait for a recovery.

The Complex Plays: CPRT and RDDT

CPRT (Copart): Built a sophisticated multi-leg position:

• Bought 200 shares at $50.19

• Sold calls and puts while hedging with long calls

• Net options income: $134.84

• Current status: Stock slightly underwater but options providing cushion

RDDT (Reddit): My most aggressive play - a short strangle generating $954.80 in total premium:

• Sold 2 calls at $121 strike (rolled from $120)

• Sold 1 put at $115 strike

• With RDDT at $118.18, I'm perfectly positioned in the profit zone

Trade Management: The Real Edge

The difference between profitable options trading and gambling lies in active management. This week showcased three key techniques:

1. Rolling Winners

When my AMAT calls dropped to $0.02 on expiration day, I bought them back and immediately sold next week's calls for $1.62. This "roll for credit" generated an additional $104+ while maintaining the position.

2. Strategic Assignment

Rather than panic-closing the LULU put, I accepted assignment. With 100 shares now in hand, I can sell covered calls to reduce my cost basis over time.

3. Multi-Timeframe Positioning

While most positions expired weekly, my CPRT complex trades extend to July, providing longer-term income potential.

What's Working (And What Isn't)

Working:

• Covered calls on existing positions: ASML generated $366 in pure options income

• Short-term time decay: Weekly options provided excellent risk-adjusted returns

• Active rolling: Extended profitable positions rather than letting them expire

Challenging:

• Naked puts in volatile markets: LULU's sharp drop shows the assignment risk

• Position sizing: Larger positions like RDDT strangle require careful monitoring

Current Portfolio: What I'm Watching

Current Open Positions: Week 3 Setup

Total Premium at Risk: $1,350.96

Risk Management Notes:

• RDDT positions are well-positioned with stock at $118

• AMAT covered calls should be safe with stock at $170

• CPRT puts need monitoring if stock continues declining

Lessons From Week 2

1. Premium collection works: Even with one assignment, the week generated significant income

2. Quality underlying matter: My ASML and RDDT positions benefited from strong stocks

3. Trade management is crucial: Rolling and active management added hundreds in additional income

4. Assignments aren't failures: They're part of the strategy when you choose quality names

Looking Ahead

Next week brings another round of weekly expirations on June 20th. My focus will be:

• Managing the RDDT strangle as it approaches expiration

• Potential covered calls on my new LULU position

• Monitoring CPRT for additional option opportunities

• Identifying new weekly income positions for June 27th expiration

The goal remains consistent: generate 2-4% monthly returns through systematic options income while building positions in quality companies.

Total week impact: $2,370 in options income - $2,089 LULU assignment loss = +$281 net for the week.

This demonstrates both the income potential and assignment risks of systematic options trading.

Disclaimer: This is educational content documenting actual trades. Options trading involves significant risk and is not suitable for all investors. Always do your own research and consider your risk tolerance.

ASML continues to dominate the semiconductor equipment industry with its monopoly on EUV lithography technology. Despite Q1 2025 bookings coming in below expectations at $4.4 billion, the company maintains strong fundamentals with 54% gross margins and guides for $34-40 billion in 2025 revenue. Trading at a P/E of 29.7x, ASML commands a premium valuation justified by its technological moat and exposure to AI-driven semiconductor demand.

The Numbers That Matter

Financial Performance (2024 vs 2015)

Q1 2025 Update

ASML reported Q1 2025 results on April 16, 2025:

• Revenue: $8.7 billion (in line with guidance)

• Gross Margin: 54.0% (above 50-52% guidance)

• Net Income: $2.7 billion

• Net Bookings: $4.4 billion (below $5.5B consensus)

• EUV Bookings: $1.4 billion of total bookings

The Monopoly Moat

ASML's competitive advantage is unparalleled in the semiconductor industry:

1. 100% market share in EUV lithography - No viable competitors

2. 80%+ market share in ArF immersion - Critical for advanced nodes

3. Installed base of 500+ systems generating recurring revenue

4. 15+ years ahead of competition in EUV technology

Technology Leadership by the Numbers

Financial Strength

Key Metrics Excellence

Interest Coverage

With $15.1B in cash and minimal debt, ASML has fortress-like balance sheet strength. Interest coverage exceeds 100x, providing complete financial flexibility.

Valuation Analysis

Current Valuation Metrics

Valuation Premium Justified By:

1. Monopoly position in critical technology

2. Superior margins (51%+ gross margins vs 40-45% for peers)

3. Higher growth potential from AI and advanced nodes

4. Pricing power with 3-5 year order backlogs

Competitive Landscape

Market Position vs Key Competitors

*Estimated based on market data

Enterprise Value Comparison

Growth Catalysts

1. AI Semiconductor Boom

• AI chips require most advanced nodes (3nm, 2nm)

• Each new node requires 2-3x more EUV layers

• High-NA EUV adoption starting in 2025-2026

2. Geographic Expansion

• $34-40B 2025 guidance implies 1-19% growth

• China represented 32% of Applied Materials revenue

• ASML less exposed but benefits from global capacity adds

3. Technology Transitions

• GAA (Gate-All-Around) requiring more lithography steps

• Advanced packaging needing lithography equipment

• Emerging memories (HBM, MRAM) driving tool demand

Risk Factors

1. Geopolitical Tensions

• Export restrictions to China (though ASML has exemptions)

• Tariff uncertainties impacting customer spending

• Regional semiconductor capacity buildouts

2. Cyclical Exposure

• Memory spending remains volatile

• Customer concentration (TSMC, Samsung, Intel)

• Long lead times amplify cycle impacts

3. Valuation Risk

• Trading at 10-year high multiples

• Limited upside if growth disappoints

• Competition in DUV from Canon/Nikon

Investment Thesis

Bull Case (Target: $1,075)

• AI drives sustained 15%+ revenue CAGR

• High-NA EUV adoption exceeds expectations

• Gross margins expand to 55%+ by 2026

• Multiple expansion to 35x P/E on monopoly premium

Base Case (Target: $935)

• 10-12% revenue CAGR through 2027

• Steady margin improvement to 52-53%

• Current multiples maintained

• Continued technology leadership

Bear Case (Target: $735)

• Cyclical downturn deeper than expected

• China restrictions expanded

• Gross margins compress to 48-50%

• Multiple compression to 25x P/E

The Bottom Line

ASML remains the crown jewel of semiconductor equipment with an unassailable competitive position. While near-term bookings disappointed and tariff uncertainties loom, the company's monopoly on EUV technology makes it indispensable for advancing Moore's Law.

For long-term investors: ASML offers exposure to secular semiconductor growth with pricing power few companies possess. The premium valuation is justified by superior returns and competitive positioning.

For traders: Wait for pullbacks below $720 for better entry points given elevated valuations and near-term uncertainties.

Overall Rating: BUY with a 12-month target of $935 (21% upside)

Key Takeaways:

• Monopoly business model with 50%+ gross margins

• ROIC of 36% demonstrates exceptional capital efficiency

• $10.8B in 2024 FCF provides ample capital return flexibility

• AI semiconductor demand provides multi-year growth runway

• Premium valuation justified but limits near-term upside

Disclosure: This analysis is for informational purposes only and not investment advice. Do your own research before making investment decisions.

Copart Inc. (NASDAQ: CPRT) stands as the undisputed leader in the online vehicle auction industry, commanding approximately 40% market share in the American automotive auction market. In 2025, Copart maintains a commanding position in the American automotive auction market. The company accounts for nearly 40% of the industry's market share. With fiscal 2024 revenue reaching $4.24 billion and net income of $1.36 billion, the company has demonstrated remarkable consistency in both growth and profitability over the past two decades.

Key Investment Highlights:

• Market-leading position with significant competitive moats

• Exceptional financial performance with 32% net margins

• Strong secular tailwinds from increasing vehicle complexity

• Robust free cash flow generation ($965M in fiscal 2024)

• Trading at 34x P/E ratio reflecting premium valuation

Company Overview

Founded in 1982, Copart operates the world's largest online vehicle auction platform, processing over 4 million vehicles annually across 11 countries through more than 250 locations. The company primarily serves insurance companies by auctioning vehicles declared total losses, but has expanded to serve banks, rental companies, fleet operators, and individual consumers.

Business Model Strengths

Copart's asset-light model acts as a marketplace rather than taking inventory risk. The company generates revenue through:

• Service fees from vehicle processing and storage

• Auction fees charged to buyers and sellers

• Transportation and logistics services

• Additional services like parts sales and vehicle inspections

Financial Performance Analysis

Revenue Growth Trajectory

Copart has delivered exceptional long-term growth, with revenue expanding from $254 million in fiscal 2001 to $4.24 billion in fiscal 2024 - a compound annual growth rate of approximately 13%. The growth has been particularly impressive over the past five years:

Profitability Excellence

One of Copart's most impressive characteristics is its consistent profitability improvement. Net margins have expanded from 16.8% in fiscal 2001 to 32.2% in fiscal 2024, demonstrating exceptional operational leverage:

Key Profitability Metrics (Fiscal 2024):

• Gross Margin: 45.0%

• Operating Margin: 37.1%

• Net Margin: 32.2%

• Return on Equity: 20.2%

• Return on Assets: 18.0%

Balance Sheet Strength

Copart maintains a fortress-like balance sheet with minimal debt and substantial cash reserves:

Balance Sheet Highlights (Fiscal 2024):

• Total Assets: $8.43 billion

• Cash and Equivalents: $1.51 billion

• Total Debt: $0 (essentially debt-free)

• Shareholders' Equity: $7.52 billion

• Current Ratio: 8.2x

Cash Generation Machine

The company consistently generates substantial free cash flow, converting earnings into cash efficiently:

Industry Dynamics and Competitive Position

Market Structure

The North American salvage vehicle auction market is highly consolidated, with the top two competitors, Copart and IAAI, representing an estimated 37% and 35% of the market, respectively, and no other competitor representing more than 10%. This duopoly structure provides significant competitive advantages.

Secular Growth Drivers

Several powerful trends support Copart's long-term growth prospects:

1. Vehicle Complexity Increases Total Loss Rates The expense of fixing vehicles, which are replete with computer chips, ADAS equipment and advanced electronics, is less enticing to insurance companies than paying out the vehicle's worth. Modern vehicles contain increasingly sophisticated technology that makes repairs more expensive than replacement.

2. Record Total Loss Frequency The full-year trend of 22.2% represents an all-time annual high, and the total loss frequency drivers certainly continue unabated. This trend is expected to continue as vehicles become more complex.

3. Natural Disasters and Climate Events Catastrophic events from late last year, including hurricanes Milton and Helene, contributed to the increased number of totaled vehicles. Climate change is increasing the frequency and severity of weather-related vehicle damage.

Competitive Advantages

Copart benefits from several defensive moats:

• Network Effects: More buyers attract more sellers, and vice versa

• Scale Economies: Fixed costs spread across millions of vehicles

• Land Ownership: Strategic real estate positions near population centers

• Technology Leadership: Proprietary VB3 auction platform and Copart 360 imaging

• Switching Costs: Integrated relationships with insurance companies

Recent Performance and Management Commentary

Q2 2025 Results Highlights

Copart beat Wall Street's expectations in Q1 2025 and has exceeded expectations for three of the past five quarters. Recent quarterly performance showed:

• Global volume growth: 8% year-over-year in Q2 2025

• Blue Car service growth: Exceeded 27% year-over-year

• Purple Wave growth: 8% growth in heavy machinery and farming equipment auctions

However, the stock faced some pressure after recent earnings: Shares of leading online vehicle auction platform Copart (CPRT -1.40%) were down 12% as of noon ET Friday, according to data provided by S&P Global Market Intelligence. Copart reported earnings on Friday and delivered sales and earnings per share growth of 8%. This top-line figure missed analysts' expectations, and the stock sold off as a result.

International Operations

Copart's international expansion continues, though with mixed results. Abroad, the company reported that international purchased vehicle revenue decreased by over $18 million or 22%. However, this was accompanied by an increase in gross profit, partly due to changes in the business model in Germany and stronger margins in the UK.

Risk Factors and Challenges

Near-term Headwinds

1. Uninsured Population Growth The company acknowledged a "modest increase in the uninsured population relative to pre-COVID levels." Fewer insured vehicles could disrupt the company's flow of totaled cars and parts into its marketplaces.

2. Tariff Uncertainty While management believes tariffs could be neutral to positive for business, President Donald Trump announced potential tariffs on all Canadian and Mexican imports, starting March 4. The added taxes could impact Copart's underlying numbers, potentially increasing repair costs while also raising pre-accident values.

3. Valuation Concerns Trading at 43 times earnings prior to the report, Copart was priced with the lofty expectation that it'd continue growing sales by its historical double-digit average, and came up just shy.

Long-term Considerations

• Electric vehicle adoption could change salvage patterns

• Autonomous vehicle technology may reduce accident rates

• Economic downturns could impact vehicle sales and insurance coverage

Valuation Analysis

Current Metrics

Trading Statistics (as of June 2025):

• Stock Price: $50.13

• Market Cap: $49.7 billion

• Trailing P/E: 34.1x

• Forward P/E: 29.6x

• Price-to-Sales: 10.8x

• Price-to-Book: 5.7x

• Enterprise Value/EBITDA: ~25x

Historical Context

Copart has historically traded at premium valuations due to its:

• Dominant market position

• Consistent growth track record

• High-quality business model

• Strong competitive moats

Since going public in 1994, Copart has become a 398-bagger, generating an annualized total return of 21%.

Forward-Looking Considerations

The current valuation appears demanding but may be justified by:

• Continued secular growth in total loss rates

• International expansion opportunities

• Adjacent market penetration (Purple Wave, Blue Car)

• Technology-driven efficiency gains

Investment Recommendation

Rating: HOLD with a bias toward BUY on weakness

Copart represents one of the highest-quality businesses in the public markets, with an exceptional track record of growth and profitability. The company benefits from powerful secular tailwinds that should drive growth for years to come.

Bull Case

• Market-leading position with significant moats

• Secular growth from increasing vehicle complexity

• Strong balance sheet enables opportunistic expansion

• Technology leadership drives operational efficiency

• International expansion provides long-term upside

Bear Case

• Premium valuation leaves little room for disappointment

• Cyclical headwinds from insurance industry dynamics

• Potential disruption from autonomous vehicles

• Economic sensitivity despite defensive characteristics

Target Price and Recommendation

Based on historical valuations and growth prospects, a fair value range of $52-58 per share appears reasonable, representing 25-30x forward earnings on estimated 2026 EPS of $2.00-2.20.

Action: Current investors should hold their positions, while new investors should consider building positions on any weakness below $48 per share. The combination of secular growth trends and market leadership makes Copart an attractive long-term holding despite current valuation concerns.

Conclusion

Copart Inc. stands as a testament to the power of network effects and market leadership in creating sustainable competitive advantages. While the current valuation reflects high expectations, the company's position at the intersection of several powerful secular trends - vehicle complexity, climate change, and digitalization - provides a compelling long-term investment thesis.

The recent stock weakness following earnings presents an opportunity for patient investors to add to positions in one of the market's highest-quality compounding machines. With its debt-free balance sheet, consistent cash generation, and dominant market position, Copart is well-positioned to continue delivering superior returns to shareholders over the long term.

Disclaimer: This analysis is for informational purposes only and should not be considered as investment advice. Please conduct your own research and consult with a financial advisor before making investment decisions.